CardioComm Solutions, Inc.
TSX VENTURE : EKG

CardioComm Solutions, Inc.

March 09, 2011 18:09 ET

CardioComm Solutions, Inc. Closes Debt Settlement

VICTORIA, BRITISH COLUMBIA--(Marketwire - March 9, 2011) - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company") today announced that it has closed its previously announced debt settlement under which it issued 1,400,000 common shares in recognition of $70,000 worth of services provided by four firms with a long term relationship with the Company. The shares issued are subject to a four month hold period expiring July 2, 2011.

Etienne Grima, CEO of the Company, said, "the offer by our closest advisors and consultants to accept our shares demonstrates a shared commitment to our long term vision in becoming the leader for the provision of ECG monitoring and patient management software solutions. As can be appreciated, these companies know us well and understand our capabilities to meet our stated goals."

About CardioComm Solutions, Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global EKG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions, Inc.

Dr. Anatoly Langer, Chairman

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Contact Information